Browse studies

Find your next paid study

2,202 recruiting studies matching your filters

Double Blind Randomized Trial of Post-operative Cesarean Continuous Infusion of Bupivacaine Versus Placebo for Local Incisional Pain Control

This study plans to learn more about postoperative pain management after cesarean deliveries (C-sections). As a part of standard of care, the Children's Hospit…

Post-operative PainCesarean Section

Estimated

~$10 – $6,250

University of Colorado, DenverNCT05131178

PREVENT: Preparedness Through Respiratory Virus Epidemiology and Community Engagement

The CHARM network will be established through three primary institutions-Beth Israel Deaconess Medical Center (BIDMC), the University of California San Diego (…

Respiratory Infection VirusCOVID -19RSV+1 more

Estimated

~$10 – $750

University of California, San DiegoNCT07147517

Phase 1

TCR-αβ+ and CD19+ Depleted KIR/KIR Ligand-mismatched Haploidentical Hematopoietic Stem Cell Transplant and Zoledronate for Pediatric Relapsed/Refractory Hematologic Malignancies and High Risk Solid Tumors

This phase I trial studies the safety of transplantation with a haploidentical donor peripheral blood stem cell graft depleted of TCRαβ+ cells and CD19+ cells …

Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaHodgkin Lymphoma+8 more

Estimated

~$10 – $6,250

University of Wisconsin, MadisonNCT02508038

Observational

Efficacy and Safety of Functional Neurogenesis Stimulation Therapy in Children With Autism Spectrum Disorder: A Multicenter, Randomized Controlled Trial

This study will test whether a noninvasive brain stimulation treatment called Functional Neurogenesis Stimulation (using the NeuroCytontron device) can safely …

Autism Spectrum Disorder

Estimated

~$10 – $8,750

Neurocytonix, Inc.NCT07276555

Phase 3

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection Fraction, SPIRRIT-HFPEF

Heart failure with preserved ejection fraction (HFPEF) is common and deadly but without therapy. Inconclusive studies such as TOPCAT (Treatment of Preserved Ca…

Heart Failure With Preserved Ejection Fraction

Estimated

~$10 – $6,250

Uppsala UniversityNCT02901184

Phase 1

GUARDIAN-101: A Phase 1 Dose Escalation and Expansion Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Phase 1 dose escalation and expansion study of CLSP-1025, a first-in-class HLA-A\*02:01 specific T cell engager (TCE) targeting solid tumors that harbor the p5…

Advanced Solid TumorUnresectable Solid TumorMetastatic Solid Tumor+8 more

Estimated

~$10 – $8,750

Clasp Therapeutics, Inc.NCT06778863

Measuring the Impact of Onco4D® Guidance

Millions of cancer patients each year receive chemotherapy causing adverse side effects that lower quality of life without prolonging it. Reliable identificati…

CancerChemotherapy Effect

Estimated

~$10 – $1,050

Animated Dynamics, Inc.NCT04891952

The Utility and Feasibility of Mt-sDNA as a Surveillance Procedure in Colorectal Cancer Survivors

The purpose of this research study is to determine whether testing of stool for a panel of markers will enable us to detect polyps and cancer compared to stand…

Adenocarcinoma of the ColonAdenocarcinoma of the RectumStage I Colorectal Cancer+2 more

Estimated

~$10 – $750

Case Comprehensive Cancer CenterNCT04624555

Phase 2

A Phase 2, Open-label, Multicenter Study of IBI363 (PD1-IL2m) in Subjects with Advanced Solid Malignancies

This is a Phase 2, open-label, multicenter study designed to evaluate the efficacy, safety and tolerability of IBI363 (study drug) in subjects with advanced, r…

MelanomaNon-small Cell Lung CancerColorectal Cancer+1 more

Estimated

~$10 – $8,750

Innovent Biologics (Suzhou) Co. Ltd.NCT06281678

Observational

GENOCARE: A Prospective, Randomized Clinical Trial of Genotype-Guided Dosing Versus Usual Care

This is a prospective, randomized study designed to compare genotype-guided dosing to usual care in patients with pancreas cancer and colorectal cancer who are…

Colorectal CancerPancreatic Cancer

Estimated

~$10 – $7,500

Reema A. PatelNCT05391126

An Observational Post-Intervention Control Destination Cohort

This study is being done to see if people who control HIV without antiretroviral therapy (ART) after receiving an intervention can remain off ART safely. The i…

HIV-1-infection

Estimated

~$10 – $675

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT05985642

Phase 1

Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts

This is a Phase I dose-escalation study to evaluate the safety of norovirus -specific T-cell (NST) therapy for chronic norovirus infection in participants foll…

Viral InfectionHematopoietic Stem Cell Transplantation (HSCT)Primary Immunodeficiency Disorders (PID)

Estimated

~$10 – $5,625

Children's National Research InstituteNCT04691622